Інструкція із застосування SORBISTERIT
Зміст інструкції
- What is Sorbisterit and what is it used for
- What you need to know before you use Sorbisterit
- How to use Sorbisterit
- Possible side effects
- How to store Sorbisterit
- Contents of the pack and other information
Sorbisterit, powder for oral/rectal suspension
Polystyrene sulphonate calcium
Read this leaflet carefully beforeusingthis medicine as it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Contents of this leaflet:
- 1. What Sorbisterit is and what it is used for
- 2. What you need to know before you use Sorbisterit
- 3. How to use Sorbisterit
- 4. Possible side effects
- 5. How to store Sorbisterit
- 6. Contents of the pack and other information
1. What is Sorbisterit and what is it used for
Sorbisterit is used in the treatment of hyperkalemia (increased potassium content in the
blood) in patients with kidney disorders or undergoing dialysis (removal of waste products from the blood).
Sorbisterit is a cation exchange resin (insoluble structure that releases certain ions in exchange
for other ions) that exchanges potassium for calcium in the intestine. Consequently, it reduces the absorption of
potassium into the blood.
2. What you need to know before you use Sorbisterit
Do not use Sorbisterit
- if your blood contains too little potassium, manifested in a severe form as muscle cramps or muscle weakness and fatigue
- if your blood contains too much calcium
- if you are allergic to calcium polystyrene sulfonate or any of the other ingredients of this medicine (listed in section 6)
- if you suffer from constipation or intestinal obstruction
- in case of concomitant intake of sorbitol (a laxative)
- in newborns orally
- in newborns with constipation
Warnings and precautions
Talk to your doctor or pharmacist before using Sorbisterit.
- if used orally. You must use it while sitting upright to prevent inhalation of the liquid.
- if you suffer from constipation, consult your doctor before using this medicine.
The electrolyte content in the blood must be checked daily.
Tell your doctor if any of the above warnings apply to you now or have applied to you in the
past.
Children
Particular attention must be paid when used in children and newborns, as an
overdose or incorrect dilution may cause the resin to have too strong an effect. Particular caution is needed in subjects with reduced body weight, especially
newborns, taking into account any gastrointestinal bleeding and due to the risk of colon death
(necrosis).
Other medicines and Sorbisterit
Tell your doctorif you are taking, have recently taken or might take any other
medicines. The concomitant administrationwith other medicines taken orallymust
be avoided. Sorbisterit must be taken at least three hours before or three hours after taking other
medicines orally. For patients with gastroparesis, a six-hour interval should be considered.
You should consult your doctor in particular if you are taking:
- sorbitolshould not be used as a laxative, as this may cause damage to the colon (necrosis)
- medicines containing potassium;
- medicines for the treatment of heartburn or laxatives, such as magnesium hydroxide, aluminum hydroxide or calcium carbonate.
- medicines that increase heart efficiency, such as digoxin (cardiac glycosides), as their action may be increased;
- Lithium:an antidepressant, as its absorption may be reduced by Sorbisterit.
- L-thyroxine: Sorbisterit reduces the absorption and consequently the effect of this thyroid drug.
- Medicines that interact with calcium:or oral Ciprofloxacin:an antibiotic, its effect is reduced by Sorbisterit; or oral Tetracyclines:an antibiotic, its effect is reduced by Sorbisterit.
- medicines that remove fluids from tissues, such as hydrochlorothiazide (thiazide diuretics) or furosemide and torasemide (loop diuretics);
- Certain drugs that affect nerve cells or nerve fibers(anticholinergics) as there is an increased risk of side effects of Sorbisterit on the stomach.
Sorbisterit with food and drink
Sorbisterit should not be used with fruit juices (e.g. pineapple, grapefruit,
orange, tomato or grape juice) rich in potassium, as this may counteract the action of
Sorbisterit.
Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with
breast milk, ask your doctor or pharmacist for advice before using this medicine.
The use of Sorbisterit is contraindicated during pregnancy or breastfeeding unless its
use is deemed essential by your doctor.
Driving and using machines
No effects on the ability to drive or operate machinery are known.
Sorbisterit contains sucrose
If your doctor has diagnosed you with an intolerance to certain sugars, contact him before taking
this medicine.
3. How to use Sorbisterit
Use this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, ask your doctor or pharmacist.
The necessary duration of treatment depends on daily measurements of potassium in the blood.
The recommended dose is:
Oral use
- Adults and elderly:1 measuring tablespoon (20 g of powder) 1 - 3 times a day, dissolved in approximately 150 ml of liquid.
- Children:0.5 - 1 g of powder per kilogram of body weight per day, dissolved in approximately 150 ml of liquid. This preparation must be used in at least three separate doses over a 24-hour period. Suitable liquids are water, tea or soft drinks. Sorbisterit must be used with meals in an upright position. Concomitant administration with other orally administered medicines should be avoided (see section 2).
Rectal use
- Adults and elderly:After using an enema, dissolve 2 measuring tablespoons of Sorbisterit (40 g) in 150 ml of 5% glucose solution and administer rectally 1 - 3 times a day. Retention time: 6 hours.
- Children:Rectal administration is used in cases where Sorbisterit cannot be swallowed. Dissolve 0.5 - 1 g of powder per kilogram of body weight per day in 150 ml of 5% glucose solution and administer in at least 3 separate doses over 24 hours. Six hours after introduction into the anus, the colon must be irrigated to remove the resin.
If you think that the effect of Sorbisterit is too strong or too weak, contact your doctor or pharmacist.
If you use more Sorbisterit than you should
If you have used too much Sorbisterit, contact your doctor or pharmacist immediately. In general,
an overdose of Sorbisterit can cause a decrease in blood potassium levels
(hypokalaemia) with symptoms such as cramps, leg pain while sitting, extreme weakness and
occasionally, paralysis. Abnormal heart rate may occur. Other undesirable effects of
overdose may manifest as an increase in blood calcium levels
(hypercalcemia) with symptoms such as fatigue, muscle weakness, frequent urination, constipation,
abnormal heart rate, kidney failure or coma. Furthermore, an overdose can
cause constipation, bowel obstruction and fluid accumulation.
If you forget to use Sorbisterit
Ask your doctor or pharmacist for advice.
Do not take a double dose to make up for a missed dose.
If you stop taking Sorbisterit
The consequence may be an increase in blood potassium content.
If you have any questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The classification of side effects is based on the following frequencies:
very common: may affect more than 1 in 10 people
common: may affect up to 1 in 10 people
uncommon: may affect up to 1 in 100 people
rare: may affect up to 1 in 1,000 people
very rare: may affect up to 1 in 10,000 people, including isolated cases
not known: frequency cannot be estimated from the available data
common:
- too much calcium in the blood
- too little potassium in the blood, which can manifest in severe forms with muscle cramps or muscle weakness and fatigue
- too little magnesium in the blood
- nausea
- vomiting
uncommon:
- constipation
- diarrhoea
- stomach ulcers
- damage to the colon, which can lead to perforation of the intestine
- loss of appetite
- intestinal blockage
rare:
- complete intestinal blockage due to, in the most severe cases:
- accumulation of resin in the intestine
- “thickening” of the stools after rectal use in children
- formation of occlusions after oral use in newborns
- cases of bleeding from the anus have been reported after rectal use in premature infants with low birth weight and in newborns. very rare:
- acute inflammation of the airways, manifested with cough and elevation of the diaphragm and/or a particular form of pneumonia caused by inhalation of this medicine.
In case of oral use, you may have difficulty swallowing a high quantity of dissolved powder.
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your
doctor or pharmacist. You can also report side effects directly through the
national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-
avverse By reporting side effects you can help provide more information on the
safety of this medicine.
5. How to store Sorbisterit
Keep this medicine out of the sight and reach of children.
Keep the container tightly closed to protect the medicine from moisture.
Do not use this medicine after the expiry date which is stated on the pack after “Exp”. The
expiry date refers to the last day of that month.
Shelf life after first opening of the container: 3 months
Do not dispose of any medicine in waste water or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Sorbisterit contains:
- The active ingredient is polystyrene calcium sulfonate. 1 g of Sorbisterit contains from 759 to 949 mg of polystyrene calcium sulfonate. 20 g of Sorbisterit contains from 15.18 to 18.98 g of polystyrene calcium sulfonate.
- The other ingredients are sucrose and citric acid.
Description of the appearance of Sorbisterit and contents of the pack
Sorbisterit is a fine powder of cream or light brown color and is available in 500
g containers with a measuring device.
Marketing authorization holder and manufacturer
Marketing authorization holder
Fresenius Medical Care Nephrologica Deutschland GmbH
Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H., Germany
Manufacturer
Fresenius Medical Care Deutschland GmbH
Else-Kröner-Straße. 1
61352 Bad Homburg v.d.H., Germany
Distributed by:
Vifor Fresenius Medical Care Renal Pharma Italia S.r.l.
Tel: +39-0373 977 321

- Країна реєстрації
- Лікарська формаPowder for oral/rectal suspension, 500 G
- Код АТХV03AE01
- Діюча речовина
- Потрібен рецептНі
- Виробник
- Ця інформація надана лише для ознайомлення і не є медичною порадою. Рішення щодо лікування завжди приймає лікар.
- Альтернативи до SORBISTERITЛікарська форма: Oral suspension powder, 454 GДіюча речовина: polystyrene sulfonateВиробник: SANOFI S.R.L.Рецепт не потрібенЛікарська форма: Chewable tablet, 250 MGДіюча речовина: lanthanum carbonateПотрібен рецептЛікарська форма: Oral suspension powder, 5 GДіюча речовина: sodium zirconium cyclosilicateВиробник: ASTRAZENECA ABРецепт не потрібен
Аналоги SORBISTERIT в інших країнах
Препарати з тією самою діючою речовиною, доступні в інших країнах.
Аналог SORBISTERIT у Польща
Аналог SORBISTERIT у Іспанія
Лікарі онлайн щодо SORBISTERIT
Застосування, безпека та можливість призначення рецепта — за результатами медичної оцінки.
Отримайте рецепт на SORBISTERIT онлайн
Заповніть форму за 2 хвилини
Розкажіть про симптоми, історію хвороби та потрібний препарат.
Оберіть лікаря або ми призначимо
Оберіть спеціаліста або ми підберемо найближчого доступного лікаря.
Лікар розглядає ваш випадок
Зазвичай протягом 30 хвилин. Може ставити уточнювальні запитання в чаті.
Отримайте в будь-якій аптеці
Електронний рецепт надсилається на вашу пошту — дійсний по всій Польщі.
Часті запитання
SORBISTERIT не потребує рецепта в Італія. Ви можете обговорити з лікарем онлайн, чи підходить цей лікарський засіб для вашої ситуації.
Діюча речовина у SORBISTERIT — polystyrene sulfonate. Це допомагає визначити препарати з тим самим складом, але під іншими торговими назвами.
SORBISTERIT виробляється компанією FRESENIUS MEDICAL CARE NEPHROLOGICA DEUTSCHLAND GMBH. Назва бренду та упаковка можуть відрізнятися залежно від дистрибʼютора.
Лікарі, зокрема Сімейні лікарі, Психіатри, Дерматологи, Кардіологи, Ендокринологи, Гастроентерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Інфекціоністи, Алергологи, Геріатри, Педіатри, Онкологи, можуть оцінити доцільність застосування SORBISTERIT з урахуванням вашого стану та місцевих правил. Ви можете записатися на онлайн-консультацію, щоб обговорити симптоми та можливі подальші кроки.
Польща має добре розвинену систему охорони здоров'я у великих містах, таких як Варшава, Краків, Вроцлав і Гданськ. Аптеки широко доступні та працюють відповідно до чинного законодавства, забезпечуючи доступ до рецептурних препаратів.
Ви можете придбати SORBISTERIT у Варшаві, Кракові, Вроцлаві або Гданську в будь-якій аптеці за наявності дійсного рецепта.
Щоб отримати рецепт, ви можете скористатися Oladoctor:
Інші препарати з тією самою діючою речовиною (polystyrene sulfonate) включають KAYEXALATE, FOTSNOL, LOKELMA. Вони можуть відрізнятися торговою назвою або формою випуску, але містять той самий терапевтичний компонент. Перед зміною або початком прийому нового препарату варто проконсультуватися з лікарем.
















